Combination of Bevacizumab and Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: Some Observations About the AURELIA Trial

被引：10
作者：
Tomao, Federica [1 ]
Tomao, Silverio [1 ]
Panici, Pierluigi Benedetti [1 ]
机构：
[1] Univ Roma La Sapienza, I-00185 Rome, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 31期
关键词：
OPEN-LABEL; METAANALYSIS;
D O I：
10.1200/JCO.2014.57.6231
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3580 / 3580
页数：1
相关论文
共 6 条
[1]   An Updated Meta-Analysis of Fatal Adverse Events Caused by Bevacizumab Therapy in Cancer Patients [J].
Huang, Hongxin ;
Zheng, Yayuan ;
Zhu, Jianhong ;
Zhang, Jingjing ;
Chen, Huapu ;
Chen, Xinggui .
PLOS ONE, 2014, 9 (03)
[2]   Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial [J].
Lang, Istvan ;
Brodowicz, Thomas ;
Ryvo, Larisa ;
Kahan, Zsuzsanna ;
Greil, Richard ;
Beslija, Semir ;
Stemmer, Salomon M. ;
Kaufman, Bella ;
Zvirbule, Zanete ;
Steger, Guenther G. ;
Melichar, Bohuslav ;
Pienkowski, Tadeusz ;
Sirbu, Daniela ;
Messinger, Diethelm ;
Zielinski, Christoph .
LANCET ONCOLOGY, 2013, 14 (02) :125-133
[3]   Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial [J].
Pujade-Lauraine, Eric ;
Hilpert, Felix ;
Weber, Beatrice ;
Reuss, Alexander ;
Poveda, Andres ;
Kristensen, Gunnar ;
Sorio, Roberto ;
Vergote, Ignace ;
Witteveen, Petronella ;
Bamias, Aristotelis ;
Pereira, Deolinda ;
Wimberger, Pauline ;
Oaknin, Ana ;
Mirza, Mansoor Raza ;
Follana, Philippe ;
Bollag, David ;
Ray-Coquard, Isabelle .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (13) :1302-+
[4]   Bevacizumab increases the risk of gastrointestinal perforation in cancer patients: a meta-analysis with a focus on different subgroups [J].
Qi, Wei-Xiang ;
Shen, Zan ;
Tang, Li-Na ;
Yao, Yang .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (08) :893-906
[5]   Treatment-Related Mortality With Bevacizumab in Cancer Patients A Meta-analysis [J].
Ranpura, Vishal ;
Hapani, Sanjaykumar ;
Wu, Shenhong .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (05) :487-494
[6]   RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative, Locally Recurrent or Metastatic Breast Cancer [J].
Robert, Nicholas J. ;
Dieras, Veronique ;
Glaspy, John ;
Brufsky, Adam M. ;
Bondarenko, Igor ;
Lipatov, Oleg N. ;
Perez, Edith A. ;
Yardley, Denise A. ;
Chan, Stephen Y. T. ;
Zhou, Xian ;
Phan, See-Chun ;
O'Shaughnessy, Joyce .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (10) :1252-1260
1